Millennium Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$628K Buy
174,490
+97,928
+128% +$353K ﹤0.01% 3246
2025
Q1
$229K Buy
76,562
+54,056
+240% +$162K ﹤0.01% 3590
2024
Q4
$75.4K Buy
+22,506
New +$75.4K ﹤0.01% 3846
2024
Q2
Sell
-212,763
Closed -$860K 3963
2024
Q1
$860K Buy
212,763
+197,163
+1,264% +$797K ﹤0.01% 3052
2023
Q4
$47.6K Sell
15,600
-27,784
-64% -$84.7K ﹤0.01% 3802
2023
Q3
$130K Sell
43,384
-24,406
-36% -$73.2K ﹤0.01% 3720
2023
Q2
$254K Sell
67,790
-4,868
-7% -$18.2K ﹤0.01% 3612
2023
Q1
$243K Sell
72,658
-107,028
-60% -$358K ﹤0.01% 3773
2022
Q4
$864K Buy
+179,686
New +$864K ﹤0.01% 3279
2021
Q4
Sell
-115,671
Closed -$4.06M 5162
2021
Q3
$4.06M Buy
+115,671
New +$4.06M ﹤0.01% 2393
2021
Q2
Sell
-32,420
Closed -$2M 4977
2021
Q1
$2M Buy
+32,420
New +$2M ﹤0.01% 2811